Aktienbewertung
Konkurrenz
| Unternehmen | Börsenwert | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
AstraZeneca PLC LSE:AZN |
167,50 Mrd. £ | 15,91 % | 5/6 | -19,70 % | 9,72 % | 30,20 % | DOWN |
|
Amgen NasdaqGS:AMGN |
164,85 Mrd. $ | 7,74 % | 5/6 | 5,52 % | 5,03 % | 4,38 % | UP |
|
Gilead Sciences NasdaqGS:GILD |
144,55 Mrd. $ | -0,44 % | 4/6 | 27,72 % | -53,19 % | 3,27 % | UP |
|
Pfizer NYSE:PFE |
140,94 Mrd. $ | 2,34 % | 4/6 | -2,46 % | 35,44 % | 12,95 % | DOWN |
|
Takeda Pharmaceutical Company TSE:4502 |
6.832,81 Mrd. ¥ | 45,85 % | 4/6 | 31,00 % | -11,50 % | 13,36 % | UP |
|
Daiichi Sankyo Company TSE:4568 |
6.761,19 Mrd. ¥ | 14,99 % | 4/6 | 27,55 % | 50,19 % | 57,02 % | DOWN |
|
Coherus BioSciences NasdaqGM:CHRS |
0,12 Mrd. $ | -24,31 % | 0/6 | -140,72 % | -143,80 % | 476,92 % | DOWN |
